Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van Nieuwkoop, Ceesvan der Starre, Willize E
Stalenhoef, Janneke E
van Aartrijk, Anna M
van der Reijden, Tanny J K
Vollaard, Albert M
Delfos, Nathalie M
van 't Wout, Jan W
Blom, Jeanet W
Spelt, Ida C
Leyten, Eliane M S
Koster, Ted
Ablij, Hans C
van der Beek, Martha T
Knol, Mirjam J
van Dissel, Jaap T
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.Published in
BMC Med 2017; 15(1):70Publiekssamenvatting
In adults with febrile urinary tract infection (fUTI), data on optimal treatment duration in patients other than non-pregnant women without comorbidities are lacking.PMID
28366170ae974a485f413a2113503eed53cd6c53
10.1186/s12916-017-0835-3
Scopus Count
Collections